Janice N. Cormier

Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma

Rodabe N. Amaria, Sangeetha M. Reddy, Hussein A. Tawbi et al. · Nature Medicine · 2018 · 826 citations · Full text

Life Sciences, Immunology, Oncology +14

Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study

Ya‐Chen Tina Shih, Ying Xu, Janice N. Cormier et al. · Journal of Clinical Oncology · 2009 · 493 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

Laszlo Radvanyi, Chantale Bernatchez, Minying Zhang et al. · Clinical Cancer Research · 2012 · 433 citations · Full text

Medicine, Immunology, Oncology +17

Ethnic Differences Among Patients With Cutaneous Melanoma

Janice N. Cormier, Yan Xing, Meichun Ding et al. · Archives of Internal Medicine · 2006 · 379 citations

Medicine, Dermatology, Oncology +16

Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base

John Hyngstrom, Chung-Yuan Hu, Yan Xing et al. · Annals of Surgical Oncology · 2012 · 351 citations · Full text

Medicine, Oncology, Pathology +14